These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 7903505)

  • 1. A comparison of the onset time, duration of action, and fade characteristics of atracurium and vecuronium.
    Haines M
    AANA J; 1993 Dec; 61(6):592-6. PubMed ID: 7903505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of the dose-response and recovery time course of vecuronium and atracurium in anesthetized chinese adult patients.
    Xue FS; Li P; Liao X; Li CW; Xu YC; Liu Y; Liu KP; Sun HT
    Acta Anaesthesiol Taiwan; 2007 Mar; 45(1):9-14. PubMed ID: 17424753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onset and duration of clinical relaxation of atracurium and vecuronium in patients on chronic nifedipine therapy.
    Bell PF; Mirakhur RK; Elliott P
    Eur J Anaesthesiol; 1989 Sep; 6(5):343-6. PubMed ID: 2571501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the train-of-four fade profiles produced by vecuronium and atracurium.
    Fletcher JE; Sebel PS; Mick SA; Van Duys J; Ryan K
    Br J Anaesth; 1992 Feb; 68(2):207-8. PubMed ID: 1347231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between single twitch depression and train-of-four fade: influence of relaxant dose during onset and spontaneous offset of neuromuscular blockade.
    Power SJ; Jones RM
    Anesth Analg; 1987 Jul; 66(7):633-6. PubMed ID: 2886077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
    Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Train-of-four fade during onset of neuromuscular block with nondepolarising neuromuscular blocking agents.
    Gibson FM; Mirakhur RK
    Acta Anaesthesiol Scand; 1989 Apr; 33(3):204-6. PubMed ID: 2567104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated onset of non-depolarizing neuromuscular blocking drugs: pancuronium, atracurium and vecuronium. A comparison with succinylcholine.
    Mehta MP; Sokoll MD; Gergis SD
    Eur J Anaesthesiol; 1988 Jan; 5(1):15-21. PubMed ID: 2897912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of vecuronium, atracurium and pancuronium in divided doses: effect on onset and duration of action.
    Brady MM; Mirakhur RK; Clarke RS
    Eur J Anaesthesiol; 1988 Jul; 5(4):243-9. PubMed ID: 2904367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between twitch depression and twitch fade during neuromuscular block produced by vecuronium: correlation with the release of acetylcholine.
    Bhatt SB; Kohl J; Amann A; Nigrovic V
    Theor Biol Med Model; 2007 Jul; 4():24. PubMed ID: 17634128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between vecuronium and atracurium in myasthenia gravis.
    Chan KH; Yang MW; Huang MH; Hseu SS; Chang CC; Lee TY; Lin CY
    Acta Anaesthesiol Scand; 1993 Oct; 37(7):679-82. PubMed ID: 7902637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of vecuronium and atracurium during halothane anaesthesia in children.
    Sloan MH; Bissonnette B; Lerman J
    Anaesthesia; 1998 Jan; 53(1):36-40. PubMed ID: 9505740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The dose-response relationship and time course of the neuromuscular blockade by alcuronium].
    Pühringer F; Adler R; Mitterschiffthaler G; Koller J; Mair P; Khünl-Brady KS; Agoston S
    Anaesthesist; 1990 Oct; 39(10):508-12. PubMed ID: 1980578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Onset time and duration of action of neuromuscular block induced by increasing doses of vecuronium bromide].
    Russo R; Veschi G; Dellino E; Ciceri R; Iapichino G
    Minerva Anestesiol; 1993; 59(1-2):35-8. PubMed ID: 8097304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Train-of-four fade and neuromuscular block in rats: a comparison between pancuronium, vecuronium, and rocuronium.
    Itoh H; Shibata K; Nitta S; Kobayashi T
    Can J Anaesth; 2000 Oct; 47(10):950-5. PubMed ID: 11032268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of surgical muscle relaxation by repeat doses of vecuronium and atracurium at three different dose levels.
    Khuenl-Brady KS; Scharz S; Richardson FJ; Mitterschiffthaler G
    Eur J Anaesthesiol; 1991 Jan; 8(1):1-6. PubMed ID: 1678700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous recovery of residual neuromuscular blockade after atracurium or vecuronium during isoflurane anaesthesia.
    Erkola O; Karhunen U; Sandelin-Hellqvist E
    Acta Anaesthesiol Scand; 1989 May; 33(4):290-4. PubMed ID: 2566251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia.
    Ma H; Zhuang X
    Chin Med J (Engl); 2002 Nov; 115(11):1692-6. PubMed ID: 12609090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of atracurium by pancuronium during propofol-fentanyl-N2O anesthesia.
    Nathan N; Bonada G; Feiss P
    Acta Anaesthesiol Belg; 1996; 47(4):187-93. PubMed ID: 9093646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.